Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) EBT Margin (2019 - 2023)

Historic EBT Margin for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to 313.27%.

  • ADC Therapeutics' EBT Margin fell 2460300.0% to 313.27% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.23%, marking a year-over-year increase of 957900.0%. This contributed to the annual value of 73.68% for FY2022, which is 6678500.0% up from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' EBT Margin is 313.27%, which was down 2460300.0% from 273.3% recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' EBT Margin peaked at 0.0% during Q4 2022, and registered a low of 543120103.45% during Q3 2021.
  • Moreover, its 5-year median value for EBT Margin was 781.5% (2019), whereas its average is 39799521.05%.
  • Per our database at Business Quant, ADC Therapeutics' EBT Margin plummeted by 2000000000bps in 2021 and then surged by 2000000000bps in 2022.
  • ADC Therapeutics' EBT Margin (Quarter) stood at 15842.34% in 2019, then crashed by -88406bps to 14021379.31% in 2020, then crashed by -3774bps to 543120103.45% in 2021, then surged by 100bps to 0.0% in 2022, then crashed by -1082987170bps to 313.27% in 2023.
  • Its last three reported values are 313.27% in Q3 2023, 273.3% for Q2 2023, and 314.28% during Q1 2023.